Tsegay Beyene Weldemariam

Mr. Tsegay Beyene Weldemariam

Lecturer and Researcher
orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 August 2025 in Toxicology Reports
Verified
Journal Article
Open access
TWTsegay Beyene Weldemariam
Tsegay Beyene Weldemariam
ALAbebaye Aragaw Leminie
Abebaye Aragaw Leminie
WGWorku Gemechu
Worku Gemechu
SHSamuel Woldekidan Hirpesa
Samuel Woldekidan Hirpesa
GDGetahun Tsegaye Dibaba
Getahun Tsegaye Dibaba
TDTesfaye Tolessa Dugul
Tesfaye Tolessa Dugul
Ziziphus abyssinica Hochst. ex A. Rich., a traditionally valued Ethiopian medicinal plant, was investigated for its phytochemical composition, antioxidant potential, and acute toxicity to validate its ethnopharmacological uses. Through sequential solvent extraction (n-hexane to aqueous), methanol and ethyl acetate fractions of leaves exhibited superior antioxidant activity (DPPH EC50: 12.5 ± 0.8 μg/mL; ABTS EC50: 15.2 ± 1.0 μg/mL), correlating with high phenolic (120.5 ± 0.7 mg GAE/g) and flavonoid (85.6 ± 0.6 mg QE/g) content. Leaves consistently outperformed roots across assays, reflecting tissue-specific metabolic specialization. Comprehensive phytochemical profiling revealed alkaloids, saponins, and glycosides, with quantitative analysis demonstrating solvent-dependent metabolite recovery. Acute toxicity testing using Organization for Economic Co-operation and Development (OECD) Guideline 425, at 2000 mg/kg showed no mortality or significant biochemical alterations, though mild hepatic vacuolization was observed histologically. The study highlights Z. abyssinica's dual promise as a source of natural antioxidants with a favorable safety profile, while establishing standardized protocols for its evaluation. These findings bridge traditional knowledge with scientific validation, supporting its potential development for nutraceutical or therapeutic applications targeting oxidative stress-related pathologies.

20 May 2026 in Journal of Ayurveda and Integrative Medicine
Verified
Journal Article
Open access
TWTsegay Beyene Weldemariam
Tsegay Beyene Weldemariam
ALAbebaye Aragaw Leminie
Abebaye Aragaw Leminie
WTWossene Habtu Tadesse
Wossene Habtu Tadesse
WLWorku Gemechu Lemmi
Worku Gemechu Lemmi
SHSamuel Woldekidan Hirpesa
Samuel Woldekidan Hirpesa
TDTesfaye Tolessa Dugul
Tesfaye Tolessa Dugul
Diabetes mellitus (DM) is a global health challenge, with rising prevalence and significant economic burden, particularly in low- and middle-income countries. Current synthetic antidiabetic drugs, though effective, are associated with adverse effects, prompting interest in plant-based alternatives. This study evaluated the antidiabetic potential of Ziziphus abyssinica methanolic extract (ZAE) in streptozotocin (STZ)-induced diabetic mice. Male Swiss Albino mice were grouped into normal control, diabetic control, glibenclamide (5 mg/kg), and ZAE-treated (200, 400, 600 mg/kg) groups. Parameters were monitored for 28 days. ZAE at 600 mg/kg normalized blood glucose (148.7 ± 11.0 mg/dL vs. normal control group 148.0 ± 3.0 mg/dL, ∗P∗ >0.05), achieving a 66 % reduction (∗P ∗ < 0.001) versus diabetic controls (437.2 ± 43.6 mg/dL). Body weight recovered fully (40.5 ± 1.9 g vs. 41.2 ± 1.2 g, ∗P ∗ >0.05), contrasting with a 25 % loss in diabetic controls (∗P∗ < 0.001). Lipid profiles improved, with HDL rising (61.8 ± 3.9 vs. 33 ± 2.4 mg/dL, ∗P∗ = 0.002) and LDL declining (37.5 ± 2.4 vs. 58.8 ± 3.7 mg/dL, ∗P∗ = 0.002). Liver (ALT, AST, ALP) and renal (creatinine, urea) markers normalized (∗P∗ < 0.05). Histopathology revealed β-cell preservation (∗P∗ < 0.01) and, specifically at the 600 mg/kg, a marked reduction in hepatic inflammation and renal protection. The 600 mg/kg ZAE demonstrated novel, dose-dependent efficacy not only in glycemic control but also in pancreatic β-cell preservation and multiorgan protection, showing significant benefits in renal and cardiac tissues where glibenclamide was ineffective. These findings suggest the traditional use of Ziziphus abyssinica and highlight the potential of 600 mg/kg regimen to provide concurrent glycemic control and multi-organ protection.

1 December 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
GDGetahun Tsegaye Dibaba
Getahun Tsegaye Dibaba
ALAbebaye Aragaw Leminie
Abebaye Aragaw Leminie
WTWossene Habtu Tadesse
Wossene Habtu Tadesse
WLWorku Gemechu Lemmi
Worku Gemechu Lemmi
SHSamuel Woldekidan Hirpesa
Samuel Woldekidan Hirpesa
MCMenberework Chanyalew
Menberework Chanyalew
Background: Diabetic animals show increased plasma glucose, cholesterol, triglycerides, and low-density lipoprotein levels, along with decreased body weight and glycogen in the liver and muscles. While effective diabetic treatments are still being investigated, plants and herbs have historically contributed to treatment of ailments. The current study explores an alternative, complementary and potential treatment for diabetes. In ethno-medicine, various parts of Mangifera indica are used to treat diabetes mellitus. Methods: The present study aims at investigating antidiabetic, hypolipidemic, and histopathological analysis of Mangifera indica leaf methanolic extract (MIME) in streptozotocin-induced diabetic mice by administering different oral doses (200,400 and 600 mg/kg body weight). After induction of diabetes, the animals are assigned into six groups (one control group and five treatment groups). The treatment groups are treated by different dose of extract, and glibenclamide, and their blood glucose levels were measured. The BGL recording is done using blood glucose test strips OneTouch glucometer on weekly intervals for five weeks. Hematology and other parameters such as liver, renal and total lipid profiles were determined in normal and streptozotocin-induced diabetic mice after oral administration of the extract for 28 days. Post-treatment histopathological changes in the diabetic mice organs, like the pancreas, liver, and kidney, were assessed at the end of treatments. Results: Daily oral administration of MIME (200,400 and 600 mg/kg body weight) and glibenclamide (6 mg/kg) showed significant effects on blood glucose level (P<0.001) as well as in improving kidney, liver functions and hyperlipidemia due to diabetes. The extract treatment also showed to enhanced body weight of diabetic mice as compared to diabetic control group. The NIME showed a restorative effect on pancrease, liver and kidney from the study of histopathological changes. Conclusions: Mageferin indica possess anti-diabetic property in diabetic mice. It improves body weight, liver profile, renal profile and lipid profiles. It has a favorable effect in inhibiting diabetic-induced damage of islets of Langerhans in the pancreas.